Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study
在无肝硬化的丙型肝炎病毒基因1型感染患者中，西美普韦联合索非布韦（分别治疗12周和8周）的疗效：OPTIMIST-1，一项3期随机研究
期刊:Hepatology
影响因子:15.8
doi:10.1002/hep.28467
Kwo, Paul; Gitlin, Norman; Nahass, Ronald; Bernstein, David; Etzkorn, Kyle; Rojter, Sergio; Schiff, Eugene; Davis, Mitchell; Ruane, Peter; Younes, Ziad; Kalmeijer, Ronald; Sinha, Rekha; Peeters, Monika; Lenz, Oliver; Fevery, Bart; De La Rosa, Guy; Scott, Jane; Witek, James
